Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 2
2003 1
2007 1
2008 3
2009 11
2010 10
2011 11
2012 12
2013 11
2014 10
2015 12
2016 13
2017 26
2018 40
2019 84
2020 128
2021 84
2022 58
2023 21
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 31182530

482 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
Hagihara M, Kato H, Sugano T, Okade H, Sato N, Shibata Y, Sakanashi D, Asai N, Koizumi Y, Suematsu H, Yamagishi Y, Mikamo H. Hagihara M, et al. Int J Antimicrob Agents. 2021 May;57(5):106330. doi: 10.1016/j.ijantimicag.2021.106330. Epub 2021 Mar 28. Int J Antimicrob Agents. 2021. PMID: 33789129
Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing Enterobacteriaceae in the Neutropenic Murine Lung Infection Model.
Asempa TE, Motos A, Abdelraouf K, Bissantz C, Zampaloni C, Nicolau DP. Asempa TE, et al. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02382-18. doi: 10.1128/AAC.02382-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30670411 Free PMC article.
In Vivo Efficacy of Meropenem with a Novel Non-β-Lactam-β-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model.
Monogue ML, Giovagnoli S, Bissantz C, Zampaloni C, Nicolau DP. Monogue ML, et al. Antimicrob Agents Chemother. 2018 Aug 27;62(9):e02596-17. doi: 10.1128/AAC.02596-17. Print 2018 Sep. Antimicrob Agents Chemother. 2018. PMID: 30012751 Free PMC article.
Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering.
Barnes MD, Winkler ML, Taracila MA, Page MG, Desarbre E, Kreiswirth BN, Shields RK, Nguyen MH, Clancy C, Spellberg B, Papp-Wallace KM, Bonomo RA. Barnes MD, et al. mBio. 2017 Oct 31;8(5):e00528-17. doi: 10.1128/mBio.00528-17. mBio. 2017. PMID: 29089425 Free PMC article.
482 results